Geoffrey von Maltzahn

Geoffrey von Maltzahn
NationalityAmerican
Alma materMassachusetts Institute of Technology (S.B.)
University of California, San Diego (M.S.)
Massachusetts Institute of Technology (Ph.D.)
AwardsLemelson-MIT Student Prize (2009)
National Inventors Hall of Fame Collegiate Inventors Competition Graduate Prize (2009),
Massachusetts Institute of Technology Randolph G Wei Award (2003)
Scientific career
FieldsBioengineering

Geoffrey von Maltzahn (born July 22, 1980) is an American biological engineer and businessman in the biotechnology and life sciences industry. Von Maltzahn has cofounded companies including Indigo Agriculture,[1] Generate Biomedicines,[2] Seres Therapeutics,[3] Tessera Therapeutics,[4] and Quotient Therapeutics.[5]

  1. ^ Mabe, Annalise (November 8, 2022). "The Tiny, Unexpected Key to Reversing a Future Food Shortage". The Daily Beast. Retrieved June 3, 2024.
  2. ^ Brian, Gormley (September 10, 2020). "Flagship Pioneering Hatches a New Biotech Startup, Generate Biomedicines". The Wall Street Journal. Retrieved June 3, 2024.
  3. ^ Walrath, Rowan (April 19, 2023). "Microbiome Comes of Age". Boston Business Journal. American City Business Journals. Retrieved June 3, 2024.
  4. ^ Orelli, Brian (July 13, 2020). "From gene editing to gene writing". BioWorld. Clarivate. Retrieved June 3, 2024.
  5. ^ Bayer, Max (November 21, 2023). "Flagship launches first UK biotech Quotient with genome sequencing platform". Fierce Biotech. Retrieved June 3, 2024.